JPH0363571A - Inspection kit for coliform bacilli - Google Patents

Inspection kit for coliform bacilli

Info

Publication number
JPH0363571A
JPH0363571A JP1199299A JP19929989A JPH0363571A JP H0363571 A JPH0363571 A JP H0363571A JP 1199299 A JP1199299 A JP 1199299A JP 19929989 A JP19929989 A JP 19929989A JP H0363571 A JPH0363571 A JP H0363571A
Authority
JP
Japan
Prior art keywords
antibody
soln
enzyme
salmonella
coliform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1199299A
Other languages
Japanese (ja)
Inventor
Masashi Ushiyama
正志 牛山
Hiroaki Wakamoto
裕晶 若本
Yutaka Morita
裕 森田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Priority to JP1199299A priority Critical patent/JPH0363571A/en
Priority to KR1019900011544A priority patent/KR910004813A/en
Priority to GB9016851A priority patent/GB2234587B/en
Priority to FR9009851A priority patent/FR2650673B1/en
Publication of JPH0363571A publication Critical patent/JPH0363571A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

PURPOSE:To detect most of coliform bacilli by using a carrier coated with the polyclonal antibody of the strain belonging to the enteric bacteria and a compd. which conjugates a labeling enzyme with this antibody as essential constituting elements. CONSTITUTION:An anti-Salmonella antibody soln. and an Enterobacter cloacae antibody soln. are each partly mixed and the mixture is diluted with a phosphoric acid buffer soln. The soln. is dispensed into a 96-hole type microtiter plate and is incubated; thereafter, the antibody soln. is discarded and a sodium carbonate buffer soln. contg. egg white albumin is added to the plate and the plate is freeze-dried. The anti-Salmonella antibody is dissolved in the sodium carbonate buffer soln. to prepart the enzyme-labeled anti-Salmonella antibody soln. An enzyme-labeled ante-Enterobacter antibody is similarly prepd. The most of the coliform bacilli are detected in this way.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は食品や飲料水などの衛生上の指標である大腸菌
群の検定キットに関する。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a test kit for coliform bacteria, which is a sanitary indicator for foods, drinking water, and the like.

(従来の技術) 大腸菌群の公定法での定義は、「ダラム陰性の無芽胞性
の短桿菌で、乳糖を分解してガスを産生するすべての好
気性、通性嫌気性の菌」となっている。エシェリキア属
(Escherichia)及びタレプシエラ(Kle
bsiella)等の細菌がこれに属する。大腸菌群の
存在している食品・飲料水は、その取扱中に直接・間接
に大または動物の糞便・尿などに接触した機会があって
、病原菌汚染の可能性のある不潔な食品であることを意
味する。従って、大腸菌群の検査は食品衛生上非常に重
要な検査である。
(Prior art) The official definition of coliform bacteria is "all Durham-negative, non-spore-forming short rods that are aerobic and facultatively anaerobic and that decompose lactose and produce gas." ing. Escherichia and Talepsia
bsiella) and other bacteria belong to this category. Food and drinking water containing coliform bacteria must have come into direct or indirect contact with animal feces, urine, etc. during handling, and must be unclean food that may be contaminated with pathogenic bacteria. means. Therefore, testing for coliform bacteria is a very important test in terms of food hygiene.

従来、大腸菌群の測定には公定法として、ブリリアント
グリーン乳糖胆汁ブイヨン培地(BGLB)あるいは乳
糖ブイヨン培地にダーラム管を入れたものを用い、それ
に食品試料を入れて24時間あるいは48時間、35〜
37℃で培養し、ダーラム管内にガスの蓄積が見られる
か否かを観察し、ガスの蓄積の見られたものについては
さらに遠藤培地等を用いた確定試験を行わねばならない
。確定試験までを行うと48〜72時間の長時間の培養
を要する。そのため加工食品の製造所における出荷前の
検査や各工程の衛生管理などは不可能に近い。ペーパー
ストリップ等を用いた簡易法もあるにはあるが、不正確
であり、12時間程度の培養時間を要する。
Traditionally, the official method for measuring coliform bacteria is to use Brilliant Green Lactose Bile Broth Medium (BGLB) or lactose broth medium containing a Durham tube, and then add a food sample to it and wait for 24 or 48 hours for 35 to 35 hours.
Cultivate at 37° C. and observe whether gas accumulation is observed in the Durham tube. If gas accumulation is observed, further confirmatory testing using Endo medium or the like must be performed. If a definitive test is performed, a long period of culture of 48 to 72 hours is required. As a result, pre-shipment inspections and sanitary controls in each process at processed food manufacturing facilities are nearly impossible. Although there is a simple method using paper strips, etc., it is inaccurate and requires about 12 hours of culturing time.

これらの検査には無菌操作ができる設備と、よく訓練さ
れた人員が必要である。
These tests require sterile equipment and well-trained personnel.

(発明が解決しようとする課題) 最近数種類の大腸菌やサルモネラ菌検査用の酵素結合イ
ムノアッセイやDNAプローブ技術を応用した測定キッ
トが市販されている。これらは上記の方法に比べてより
簡便で検査時間も短く (約Aに)なっている。しかし
、これらは大腸菌またはサルモネラ菌など個々の菌種を
特異的に検出することを目的にしてつくられ大腸菌群全
体を検出するものではない。
(Problems to be Solved by the Invention) Recently, measurement kits applying enzyme-linked immunoassay and DNA probe technology for testing several types of Escherichia coli and Salmonella bacteria have been commercially available. These methods are simpler and require shorter testing time (approximately A) than the above methods. However, these are created for the purpose of specifically detecting individual bacterial species such as E. coli or Salmonella, and are not intended to detect the entire coliform group.

大腸菌群を検査する方法としては下記の条件が要求され
る。1)大腸菌群のほとんどが検出でき、2)操作が簡
単である。従って本発明は、それらの条件を満たした大
腸菌群の検査法及びそれに用いる器具を提供することを
目的とする。
The following conditions are required for the method of testing coliform bacteria. 1) Most coliform bacteria can be detected, and 2) It is easy to operate. Therefore, an object of the present invention is to provide a coliform testing method that satisfies these conditions and an instrument used therefor.

(課題を解決するための手段) 本発明は、腸内細菌科(enterobacteria
ceae)に属する菌株に対するポリクロナール抗体を
コーティングした担体と、当該抗体に標識酵素を結合さ
せた化合物とを、主な構成要素とする大腸菌群の検査キ
ットである。好ましくは、腸内細菌科に属する細菌の煮
沸菌体のポリクローナル抗体を担体にコーティングした
ものと、その抗体に標識酵素を結合させた酵素標識抗体
、その酵素に対する基質、及び発色原物質からなる大腸
菌群の検査キットである。
(Means for Solving the Problems) The present invention relates to the Enterobacteriaceae (enterobacteriaceae).
This is a test kit for coliform bacteria whose main components include a carrier coated with a polyclonal antibody against a strain belonging to B. ceae), and a compound in which a labeled enzyme is bound to the antibody. Preferably, Escherichia coli comprises a carrier coated with a polyclonal antibody obtained from boiled bacterial cells of a bacterium belonging to the family Enterobacteriaceae, an enzyme-labeled antibody obtained by binding a labeled enzyme to the antibody, a substrate for the enzyme, and a chromogenic substance. This is a group test kit.

腸内細菌科に属する菌株は、この科に属する細菌であれ
ばいずれの細菌であっても本発明に利用できるが、大腸
菌群、病原性をもつ腸内細菌科の細菌に交差性をもつ抗
体を得るためには、エンテロバクタ−・クロアカニ(E
nterobacter cloacae)、またはサ
ルモネラ・チフィムリウム(Salmonellat 
 himurium)が好ましい。
Any bacterial strain belonging to the Enterobacteriaceae family can be used in the present invention as long as it belongs to this family, but antibodies that have cross-reactivity to coliform bacteria and pathogenic Enterobacteriaceae bacteria To obtain Enterobacter cloacani (E.
terobacter cloacae), or Salmonella typhimurium
himurium) is preferred.

ポリクローナル抗体は煮沸菌体を例えばウサギ、ギニア
ビッグ、ラット、マウス等の動物に注射することによっ
て、その動物の血清から得られる。
Polyclonal antibodies can be obtained from the serum of animals such as rabbits, Guinea Big, rats, and mice by injecting boiled bacterial cells into the animals.

それらの抗血清をそのまま用いても良いし、公知の手段
を用いて精製しても良い。また2種以上の抗血清を混合
しても良い。担体として、プラスチック試験管、マイク
ロタイタープレート、濾紙、ニトルセルロース膜、プラ
スチックビーズ、ガラスピーズあるいは不織布等が用い
られる。標識酵素は、セイヨウワサビ・ペルオキシダー
ゼ、アルカリ・フォスファターゼ、β−ガラクトシダー
ゼ等が用いられる。ペルオキシダーゼの基質としては、
過酸化水素または過酸化尿素が用いられる。
These antisera may be used as they are, or may be purified using known means. Moreover, two or more types of antisera may be mixed. As a carrier, a plastic test tube, a microtiter plate, a filter paper, a nitrate cellulose membrane, a plastic bead, a glass bead, a nonwoven fabric, or the like is used. As the labeling enzyme, horseradish peroxidase, alkaline phosphatase, β-galactosidase, etc. are used. As a substrate for peroxidase,
Hydrogen peroxide or urea peroxide is used.

抗体と標識酵素との結合はグルタルアルデヒド法、過ヨ
ウ素酸法、マレイミド法、ピリジルジスルフィド法等の
公知の手段でなされる。発色原物質としてはABTS 
(2,2′−アジノジ(3−エチルベンゾチアゾリン)
−6′−スルホン酸)、5−アミノサリチル酸、ルミノ
ール、あるいはTMB (3,3”、5.5 ’−テト
ラメチルベンジジン)等が用いられる。アルカリ・フォ
スファターゼの基質としては、p−ニトロフェニルリン
酸、β−ガラクトシダーゼの基質としては0−またはp
−ニトロフェニル−β−D−ガラクトシド、あるいは4
−メチルウンベリフェリル−β−D−ガラクトシドが用
いられる。
The antibody and the labeled enzyme are bound by known means such as the glutaraldehyde method, the periodic acid method, the maleimide method, and the pyridyl disulfide method. ABTS as a chromogen
(2,2'-azinodi(3-ethylbenzothiazoline)
-6'-sulfonic acid), 5-aminosalicylic acid, luminol, or TMB (3,3",5.5'-tetramethylbenzidine). As a substrate for alkaline phosphatase, p-nitrophenyl phosphoric acid is used. acid, 0- or p as a substrate for β-galactosidase
-nitrophenyl-β-D-galactoside, or 4
-Methylumbelliferyl-β-D-galactoside is used.

本発明の大腸菌群の検査キットの使用方法を以下に詳し
く述べる。食品あるいは飲料水の検体を無菌の生理緩衝
液で適当量に希釈して、ブイヨン培地に加えて、37℃
で4時間以上インキュベートする。この培養液を、抗体
をコーティングした担体に加え30分間、室温でインキ
ュベートする。その際、同時に陰性対照としてバチルス
・ズブチリス(Bacillus 5ubtilis 
) IFO13719の煮沸菌体の懸濁液を同時に担体
に加え、インキュベートする。その後、未吸着物質を、
緩衝液等で数回よく洗い流す。そこに標識酵素を結合し
た抗体の溶液を加え30分間、室温でインキュベートす
る。数回緩衝液等で、洗浄し、基質あるいは基質および
発色原物質を加え、室温でインキュベートする。同様の
ことを陰性対照についても試料と同時に行う。
The method of using the coliform test kit of the present invention will be described in detail below. Dilute food or drinking water samples to an appropriate amount with sterile physiological buffer, add to bouillon medium, and incubate at 37°C.
Incubate for at least 4 hours. This culture solution is added to the antibody-coated carrier and incubated for 30 minutes at room temperature. At that time, Bacillus subtilis was also used as a negative control.
) A suspension of boiled IFO13719 cells is simultaneously added to the carrier and incubated. After that, the unadsorbed substances are
Wash thoroughly several times with buffer, etc. A solution of an antibody bound to a labeled enzyme is added thereto and incubated for 30 minutes at room temperature. Wash several times with buffer, etc., add a substrate or a substrate and a chromogenic substance, and incubate at room temperature. The same thing is done for the negative control at the same time as the sample.

30分後、希硫酸を加えて反応を停止し、吸光度あるい
は蛍光強度を測定する。インキュベート後の培養液中の
大腸菌群の菌体量が10s/m1以上ある場合は、吸光
度あるいは蛍光強度は菌体量の対数に比例する。試料の
吸光度もしくは蛍光強度が陰性対照のそれよりも2.5
倍以上あるとき、試料中の大腸菌群は陽性と判定できる
After 30 minutes, dilute sulfuric acid is added to stop the reaction, and absorbance or fluorescence intensity is measured. When the amount of coliform bacteria in the culture solution after incubation is 10 s/ml or more, the absorbance or fluorescence intensity is proportional to the logarithm of the amount of bacteria. The absorbance or fluorescence intensity of the sample is 2.5% higher than that of the negative control.
When the amount is more than double that, the coliform group in the sample can be determined to be positive.

(発明の効果) 本発明によれば、簡単な操作で感度良く、大腸菌群のほ
とんど全部が検出でき、また短時間での検査が可能であ
る検査キットを提供することができる。
(Effects of the Invention) According to the present invention, it is possible to provide a test kit that is easy to operate, has high sensitivity, can detect almost all coliform bacteria, and can be tested in a short time.

(実施例) 次に、実施例で本発明を説明する。なお、本発明は実施
例にのみ限定されるものではない。
(Example) Next, the present invention will be explained with examples. Note that the present invention is not limited only to the examples.

実施例1 サルモネラ・チフィムリウムIFO12529の煮沸菌
体の生理緩衝液pH7,4を1週間に1回、3週間ウサ
ギの腹控内に、次に1週間に1回、3週間同しウサギに
静脈注射した。8週間後に採血し、抗血清を得た。この
抗血清5−をリン酸緩衝生理食塩水にツイーン80を0
.5%含んだ液で10倍に希釈し、その2n11をホル
ミルセルロファイン(チッソ01製、商品名)にリポポ
リサンカライドを結合させたものを担体としたカラム1
0m1(サイズ:直径l cm、高さ13cm)にかけ
た。同じ緩衝液3Mでカラムを洗い、その後グリシン塩
酸緩衝液pH2,5で抗サルモネラ抗体を溶出させた。
Example 1 Boiled Salmonella typhimurium IFO12529 cells in physiological buffer pH 7.4 were intravenously injected into the abdomen of rabbits once a week for 3 weeks, then intravenously into the same rabbits once a week for 3 weeks. did. After 8 weeks, blood was collected and antiserum was obtained. Add this antiserum 5-80 to phosphate-buffered saline.
.. Column 1 using 2n11 diluted 10 times with a solution containing 5% and bound to formylcellulofine (manufactured by Chisso 01, trade name) and lipopolysancalide as a carrier.
0 m1 (size: diameter 1 cm, height 13 cm). The column was washed with the same 3M buffer, and then the anti-Salmonella antibody was eluted with glycine-HCl buffer pH 2.5.

溶出液にトリスヒドロキシルアミンをpH8,5になる
まで加え、これをリン酸緩衝生理食塩水に1夜透析した
ものを抗サルモネラ抗体溶液とした。
Tris hydroxylamine was added to the eluate until the pH reached 8.5, and this was dialyzed against phosphate buffered saline overnight to obtain an anti-Salmonella antibody solution.

エンテロバクタ−・クロアカニIFO13535の抗体
溶液も同様にして得た。
An antibody solution of Enterobacter cloacani IFO13535 was also obtained in the same manner.

これらの抗体溶液を1部ずつ混合して、その1mlを0
.01Mリン酸緩衝液pH7,2で500倍に希釈し、
96穴式マイクロタイタープレートに100μlずつ分
注した。このプレートを37℃で1時間インキュベート
した後、抗体溶液を捨てた。次に、卵白アルブミン3%
を含む0.OIM炭酸ナトリウム緩衝液p)17.5を
300plずつ各ウェルに加えて1時間、37℃でイン
キュベートした後、内容物を捨て、0.01Mリン酸緩
衝液pH1,0で3回洗浄してから水分を切った。プレ
ートを凍結乾燥してシリカゲル等の乾燥剤を入れたビニ
ール袋に入れ、4℃で保存した。
Mix these antibody solutions one part at a time and add 1 ml to 0.
.. Diluted 500 times with 01M phosphate buffer pH 7.2,
100 μl each was dispensed into a 96-well microtiter plate. After incubating the plate at 37°C for 1 hour, the antibody solution was discarded. Next, egg white albumin 3%
Including 0. Add 300 pl of OIM sodium carbonate buffer p) 17.5 to each well and incubate for 1 hour at 37°C, then discard the contents and wash 3 times with 0.01 M phosphate buffer pH 1,0. I drained the water. The plate was freeze-dried, placed in a plastic bag containing a desiccant such as silica gel, and stored at 4°C.

この状態で少なくとも6ケ月間は安定であった。It remained stable in this state for at least 6 months.

一方、先に述べた抗サルモネラ抗体40mgを、ETA
グレードのセイヨウワサビ・ペルオキシダーゼ30n+
gを0.1M炭酸ナトリウム緩衝液(pH7,0) 5
−に溶解した溶液と混合した。マグネチツクスターラー
でゆっくり撹拌しながら、1−エチル−3(3−ジメチ
ルアミノプロピル)−カルボジイミド50mgを徐々に
加え、pl(を0.IN塩酸、および0、I N水酸化
ナトリウムで6.0〜7.0に調整しながら室温で20
時間反応させた。反応液をセルロファインGCL−10
00sf (チッソ■製、商品名)のカラムに通して未
反応物を分離して取り除いた。これを酵素標識抗サルモ
ネラ抗体液とした。
On the other hand, 40 mg of the anti-Salmonella antibody mentioned above was added to ETA
Grade horseradish peroxidase 30n+
g of 0.1M sodium carbonate buffer (pH 7.0) 5
- mixed with a solution dissolved in. While slowly stirring with a magnetic stirrer, 50 mg of 1-ethyl-3(3-dimethylaminopropyl)-carbodiimide was gradually added, and the pl (pl) was diluted with 0.IN hydrochloric acid and 0.IN sodium hydroxide to 6.0~ 20 at room temperature while adjusting to 7.0.
Allowed time to react. Transfer the reaction solution to Cellulofine GCL-10
The mixture was passed through a column of 00sf (manufactured by Chisso ■, trade name) to separate and remove unreacted substances. This was used as an enzyme-labeled anti-Salmonella antibody solution.

同様にして、酵素標識抗エンテロバクター抗体を調製し
た。
Similarly, an enzyme-labeled anti-Enterobacter antibody was prepared.

一方、エシェリキア・コリに121FO3301(Es
cherichia coli)、サルモネラ・チフイ
ムリウムIFOL2529、エンテロバクタ−・クロア
カニIFO13535、イエルシニア・アルドヴアエJ
CM5892(Yersinia aldovae)、
クレブシェラ・テリゲナJCM 1687(Klebs
iella terri ena)、アエロモナス・ヒ
ドロキシル・サブスピーシーズ・ヒドロフイラJCM 
1027(へeromonas h dro hila
 5ubs eciesh dro hilla)、セ
ラチア・マルセッセンスJCM1239 (Serra
tia marcescens)、プロテウス・ヴルガ
リスIFO3851(Proteus vul ari
s)の菌体1白金耳を、それぞれブイヨン培地で35℃
、3時間培養した。この培養液を熱湯に5分間漬けた後
、放冷してから、先に調整しておいたマイクロタイター
プレートに100plずつ加えて37℃でインキュベー
トした。30分後、プレートの各ウェルを0.05%の
ツイーン20を含む蒸留水で3回洗浄した。
On the other hand, 121FO3301 (Es.
cherichia coli), Salmonella typhimurium IFOL2529, Enterobacter cloacani IFO13535, Yersinia ardovuae J
CM5892 (Yersinia aldovae),
Klebsiella terrigena JCM 1687 (Klebs
iella terri ena), Aeromonas hydroxyl subsp. hydrophila JCM
1027 (Heromonas h dro hila
5ubs eciesh dro hilla), Serratia marcescens JCM1239 (Serra
tia marcescens), Proteus vulgaris IFO3851 (Proteus vulgaris)
1 platinum loop of bacterial cells of s) was incubated in broth medium at 35°C.
, and cultured for 3 hours. This culture solution was soaked in boiling water for 5 minutes, allowed to cool, and then added in 100 pl portions to the previously prepared microtiter plate and incubated at 37°C. After 30 minutes, each well of the plate was washed three times with distilled water containing 0.05% Tween 20.

次に、2種の酵素標識抗体を1部ずつ混合したものを各
ウェルに加えて37℃でインキュベートした。30分後
、再びプレートの各ウェルを0.05%ツイーン20を
含む蒸留水で3回洗浄した。よく水気を切った後、AB
TS (2,2’−アジノジ(3−エチルベンゾチアプ
リン)−6′−スルホン酸)と0,1M過酸化水素水の
クエン酸緩衝液pH5,5混液を0.21n!加えて1
5分静置して発色させ、イムノリーダーで405nmの
吸光度を測定した。その結果を表1に示した。
Next, a mixture of two types of enzyme-labeled antibodies was added to each well and incubated at 37°C. After 30 minutes, each well of the plate was again washed three times with distilled water containing 0.05% Tween 20. After draining well, AB
A mixture of TS (2,2'-azinodi(3-ethylbenzothiapurine)-6'-sulfonic acid) and 0.1M hydrogen peroxide in citrate buffer pH 5.5 was added at 0.21N! In addition 1
The mixture was left standing for 5 minutes to develop color, and the absorbance at 405 nm was measured using an immunoreader. The results are shown in Table 1.

表1 *二級光度0.2以上を陽性とした。陰性対照は0.0
8である。
Table 1 *Second-class luminous intensity of 0.2 or more was considered positive. Negative control is 0.0
It is 8.

表1に示すように、サルモネラ、エシェリキア、イエル
シニア、エンテロバクタ−、クレブシェラで陽性の値を
示した。アエロモナス、セラチア、プロテウスでは陰性
であった。アエロモナス、セラチア、プロテウスは大腸
菌群に属さないのでこの結果は好ましい。サルモネラお
よびイエルシニアは大腸菌群には厳密にいえば属してい
ないが、食中毒の原因の菌として大腸菌群の菌とともに
検出されることが望ましいので、この結果は好ましい。
As shown in Table 1, positive values were shown for Salmonella, Escherichia, Yersinia, Enterobacter, and Klebsiella. Results were negative for Aeromonas, Serratia, and Proteus. This result is favorable because Aeromonas, Serratia, and Proteus do not belong to the coliform group. Strictly speaking, Salmonella and Yersinia do not belong to the coliform group, but this result is favorable because it is desirable to detect them together with coliform bacteria as bacteria that cause food poisoning.

実施例2 牛挽肉50gに一白金耳のエシェリキア・コリに12を
加えた後、200 mlの生理食塩水で希釈懸濁し、こ
の懸濁液ニー、0.1−10.011n1、懸濁液を生
理食塩水で103倍および10’倍に希釈した液1 m
l、0.1−10.01−をそれぞれ5本ずつのダーラ
ム発酵管を入れたBGLB培地、ダーラム発酵管を入れ
ないBGLB培地10−に接種した。
Example 2 After adding 12 pieces of Escherichia coli to 50 g of ground beef, diluting and suspending it with 200 ml of physiological saline. 1 ml of solution diluted 103 times and 10' times with physiological saline
1, 0.1-10.01- were inoculated into BGLB medium containing five Durham fermentation tubes and BGLB medium 10- without Durham fermentation tubes, respectively.

ダーラム発酵管を入れたBGLB培地は37℃で24時
間または48時間培養し、ガス発生の有無を調べた。そ
の結果を比較例として表2に示した。
The BGLB medium containing the Durham fermentation tube was cultured at 37°C for 24 or 48 hours, and the presence or absence of gas generation was examined. The results are shown in Table 2 as a comparative example.

表2 表に示すように実施例2では比較例より感度がよかった
。要した時間は比較例で48時間であったが、実施例2
では7時間と大幅に短縮された。
Table 2 As shown in the table, Example 2 had better sensitivity than Comparative Example. The time required was 48 hours in the comparative example, but in Example 2
The time was significantly shortened to 7 hours.

発酵管を入れないBGLB培地は37℃で5時間培養後
、実施例1の方法で作成した抗体吸着プレート、標識酵
素液を用いて実施例1の方法で酵素免疫測定(EL、l
5A)を行った。その結果を表3に示した。
After culturing the BGLB medium without fermentation tubes at 37°C for 5 hours, enzyme immunoassay (EL, l
5A) was performed. The results are shown in Table 3.

Claims (2)

【特許請求の範囲】[Claims] (1)腸内細菌科(enterobacteriace
ae)に属する菌株に対するポリクロナール抗体をコー
ティングした担体と、当該抗体に標識酵素を結合させた
化合物とを、主な構成要素とする大腸菌群の検査キット
(1) Enterobacteriaceae
A test kit for coliform bacteria, the main components of which are a carrier coated with a polyclonal antibody against a strain belonging to the group Ae), and a compound in which a labeled enzyme is bound to the antibody.
(2)菌株が、サルモネラ・チフィムリウム(¥Sal
monella typhimurium¥)及びエン
テロバクター・クロアカエ(¥Enterobacte
r cloacae¥)の両方である請求項1記載の検
査キット。
(2) The strain is Salmonella typhimurium (¥Sal
monella typhimurium¥) and Enterobacter cloacae (¥Enterobacter
2. The test kit according to claim 1, wherein the test kit is both R cloacae ¥).
JP1199299A 1989-08-02 1989-08-02 Inspection kit for coliform bacilli Pending JPH0363571A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP1199299A JPH0363571A (en) 1989-08-02 1989-08-02 Inspection kit for coliform bacilli
KR1019900011544A KR910004813A (en) 1989-08-02 1990-07-28 Escherichia coli test kit
GB9016851A GB2234587B (en) 1989-08-02 1990-08-01 A kit for detecting coliform bacteria
FR9009851A FR2650673B1 (en) 1989-08-02 1990-08-01 COLIFORM BACTERIA DETECTION KIT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1199299A JPH0363571A (en) 1989-08-02 1989-08-02 Inspection kit for coliform bacilli

Publications (1)

Publication Number Publication Date
JPH0363571A true JPH0363571A (en) 1991-03-19

Family

ID=16405494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1199299A Pending JPH0363571A (en) 1989-08-02 1989-08-02 Inspection kit for coliform bacilli

Country Status (4)

Country Link
JP (1) JPH0363571A (en)
KR (1) KR910004813A (en)
FR (1) FR2650673B1 (en)
GB (1) GB2234587B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05322896A (en) * 1992-04-14 1993-12-07 Yakult Honsha Co Ltd Activated sludge control method and control antibody
KR100414837B1 (en) * 2001-02-09 2004-01-13 주식회사 단바이오텍 Diagnosis kit for detection salmonella
US7179603B2 (en) 2001-11-21 2007-02-20 Kimberly-Clark Worldwide, Inc. Detection and identification of enteric bacteria

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025598A2 (en) * 1993-04-26 1994-11-10 University Of Victoria Innovation And Development Corporation Methods and compositions for salmonella-based vaccines
CA2161435C (en) * 1993-05-19 2006-01-10 Robert M. Goldsmith Detection of contaminants in food
ES2075802B1 (en) * 1993-12-02 1996-05-01 Inia PROCEDURE FOR THE SENSITIVE AND SPECIFIC DETECTION OF ERWINIA CAROTOVORA SUBSP. ATROSEPTICA THROUGH "ELISA-ENRICHMENT".
AU717173B2 (en) * 1996-09-30 2000-03-16 Sira Technologies, Inc. Detection of contaminants in food
FI980571A0 (en) * 1998-03-13 1998-03-13 Elias Hakalehto Foerfarande Foer pao visning av mikrober
RU2152037C1 (en) * 1999-08-18 2000-06-27 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Method of yersiniosis diagnosis
WO2002048712A1 (en) * 2000-12-13 2002-06-20 The Additional Director (Ipr), Defence Research & Development Organisation A method of detection of e-coli, other coliforms and pathogenic organisms in water
CN101082624B (en) * 2007-07-10 2011-05-04 杨捷琳 ELISA adsorption testing method and for detecting Enterobacter sakazakii and used antibody thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256834A (en) * 1979-04-09 1981-03-17 Syva Company Fluorescent scavenger particle immunoassay
JPS6046461A (en) * 1983-08-24 1985-03-13 Dainippon Pharmaceut Co Ltd Reagent for microbial quantification
WO1985002685A1 (en) * 1983-12-12 1985-06-20 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
EP0188603A1 (en) * 1984-08-01 1986-07-30 Advanced Biotechnology Associates, Inc. A salmonella-specific analyses reagent
EP0209554A4 (en) * 1985-01-15 1988-03-22 Unisearch Ltd IMMUNOLOGICAL ANALYSIS SYSTEMS FOR DETECTION OF SALMONELLA.
US4855227A (en) * 1985-06-07 1989-08-08 Institute For Medical Research Rapid detection of mycoplasmas
FR2598513B1 (en) * 1986-02-06 1991-12-13 Chemunex NOVEL ANTIBODY ANTIBODIES CAPABLE OF RECOGNIZING MULTIPLE YEASTS, HYBRID CELL LINES PRODUCING SUCH ANTIBODIES, THEIR PREPARATION AND THEIR USES AND APPLICATIONS IN DETECTION AND POSSIBLY IN YEAST NUMBERING
GB2189317B (en) * 1986-04-16 1990-10-24 London Polytech Method of detecting and enumerating sulphate-reducing bacteria
EP0658564B1 (en) * 1986-04-30 2002-01-16 Igen International, Inc. Electroluminescent compounds and intermediates in their synthesis
AU610925B2 (en) * 1987-07-28 1991-05-30 Tecra International Pty Ltd Detection methods
DE3835784C1 (en) * 1988-10-20 1990-05-31 Unilever N.V., Rotterdam, Nl

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05322896A (en) * 1992-04-14 1993-12-07 Yakult Honsha Co Ltd Activated sludge control method and control antibody
KR100414837B1 (en) * 2001-02-09 2004-01-13 주식회사 단바이오텍 Diagnosis kit for detection salmonella
US7179603B2 (en) 2001-11-21 2007-02-20 Kimberly-Clark Worldwide, Inc. Detection and identification of enteric bacteria

Also Published As

Publication number Publication date
KR910004813A (en) 1991-03-29
GB2234587B (en) 1994-04-06
GB2234587A (en) 1991-02-06
GB9016851D0 (en) 1990-09-12
FR2650673B1 (en) 1996-08-02
FR2650673A1 (en) 1991-02-08

Similar Documents

Publication Publication Date Title
US7642060B2 (en) Rapid resuscitation, growth, capture and detection of microorganisms
JPS5825979B2 (en) Serological method to detect the presence of Neisseria gonorrhoeae antibodies
US20110159515A1 (en) Compositions and methods for the rapid growth and detection of microorganisms
JPH0363571A (en) Inspection kit for coliform bacilli
RU2189253C1 (en) Diagnosticum for identification of escherichia coli 0157:h7 and method of its preparing
WO1996028731A1 (en) Detection of shiga-like toxins of enterohemorrhagic escherichia coli
DE19842609C2 (en) Salmonella antigen mixture and kit for the determination of antibodies against Salmonella
Halliday et al. Giardia-bile salt interactions in vitro and in vivo
CA2689946A1 (en) In situ growth, freezing and testing of cultured cells
Nicholas et al. MICROBIOLOGICAL ASSAY OF VITAMIN B 12 CONTENT OF SERUM USING EUGLENA GRACILIS.
BR0113717B1 (en) MEASUREMENT CROP AND METHOD FOR IDENTIFYING GRAM NEGATIVE MICROORGANISMS
US4492761A (en) Complement assay method
EP0217583B1 (en) Simultaneous extraction of a ligand from a sample and capture by anti-ligand therefor in ligand/anti-ligand assays
Thornley et al. Detection of gonococcal antigens in urine by radioimmunoassay
Jay Analysis of food products for microorganisms or their products by nonculture methods
EP0233048B1 (en) Method of detecting urinary tract infection or inflammation
RU2152035C1 (en) Method of brucellosis diagnosis
RU2152037C1 (en) Method of yersiniosis diagnosis
AU605178B2 (en) Detection and monitoring of chronic gram-negative infection
US20220002663A1 (en) Selective salmonella or e. coli cultivation method, compositions and uses
Gästrin et al. Evaluation of a bioluminescence assay for the detection of bacteriuria
EP0348144A2 (en) Method for treating mucus-containing immunoassay samples
Tabaqchali Rapid techniques for the identification of anaerobic bacteria and presumptive diagnosis
Wegener et al. Comparison of conventional culture methods and two commercial enzyme immunoassays for detection of Salmonella in porcine fecal samples and cecal contents
Balows et al. Clinical microbiology